Nexvet Biopharma PLC Company Profile (NASDAQ:NVET)

About Nexvet Biopharma PLC

Nexvet Biopharma PLC logoNexvet Biopharma public limited company is a clinical-stage biopharmaceutical company focused on transforming the therapeutic market for companion animals by developing and commercializing species-specific biologics. The Company's platform technology, which it refers to as PETization, is an algorithmic approach that enables the Company to create monoclonal antibodies (mAbs) a type of biologic, that are designed to be recognized as self or native by an animal's immune system, a property referred to as 100% species-specificity. PETization is designed to build upon the safety and efficacy data from clinically tested human therapies to create new therapies for companion animals. Biologics generally include mAbs, which are targeted antibodies derived from identical (clonal) cells. The Company's advanced product candidates are in pivotal-phase development: ranevetmab (or NV-01) and frunevetmab (or NV-02).

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: NVET
  • CUSIP:
Key Metrics:
  • Previous Close: $4.05
  • 50 Day Moving Average: $5.18
  • 200 Day Moving Average: $3.90
  • 52-Week Range: $2.61 - $11.30
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -2.07
  • P/E Growth: 0.00
  • Market Cap: $46.83M
  • Outstanding Shares: 11,563,000
  • Beta: 0.45
Additional Links:
Companies Related to Nexvet Biopharma PLC:

Analyst Ratings

Consensus Ratings for Nexvet Biopharma PLC (NASDAQ:NVET) (?)
Ratings Breakdown: 3 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $11.33 (179.84% upside)

Analysts' Ratings History for Nexvet Biopharma PLC (NASDAQ:NVET)
Show:
DateFirmActionRatingPrice TargetDetails
8/16/2016Credit Suisse Group AGReiterated RatingBuy$8.00View Rating Details
11/24/2015Cowen and CompanyReiterated RatingBuy$13.00View Rating Details
11/24/2015Piper Jaffray Cos.Reiterated RatingOverweight$17.00 -> $13.00View Rating Details
3/3/2015JMP SecuritiesInitiated CoverageOutperform$17.00View Rating Details
3/2/2015Bank of America Corp.Initiated CoverageBuy$15.00View Rating Details
(Data available from 8/30/2014 forward)

Earnings

Earnings History for Nexvet Biopharma PLC (NASDAQ:NVET)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/12/2016        
5/12/2016Q3($0.44)($0.50)ViewN/AView Earnings Details
11/5/2015($0.51)($0.35)ViewN/AView Earnings Details
5/8/2015Q115($0.40)($0.36)ViewN/AView Earnings Details
3/16/2015($0.55)($2.01)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Nexvet Biopharma PLC (NASDAQ:NVET)
Current Year EPS Consensus Estimate: $-1.82 EPS
Next Year EPS Consensus Estimate: $-1.96 EPS

Dividends

Dividend History for Nexvet Biopharma PLC (NASDAQ:NVET)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Nexvet Biopharma PLC (NASDAQ:NVET)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/4/2016David GearingInsiderBuy11,113$3.33$37,006.29View SEC Filing  
3/2/2016Ashraf HannaDirectorBuy1,500$3.20$4,800.00View SEC Filing  
2/26/2016Farallon Capital Management LlInsiderBuy435,000$3.19$1,387,650.00View SEC Filing  
2/24/2016Cormac G KiltyDirectorBuy3,000$3.17$9,510.00View SEC Filing  
9/10/2015Farallon Capital Management LlInsiderBuy11,100$6.46$71,706.00View SEC Filing  
9/9/2015Cormac G KiltyDirectorBuy10,000$4.79$47,900.00View SEC Filing  
2/10/2015One Funds Management Ltd Atf AMajor ShareholderBuy100,000$10.00$1,000,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Nexvet Biopharma PLC (NASDAQ:NVET)
DateHeadline
News IconCrowd & Street Monitoring Nexvet Biopharma plc (NASDAQ:NVET) - Post News (NASDAQ:NVET)
www.kentuckypostnews.com - August 23 at 6:44 PM
investornewswire.com logoWill Nexvet Biopharma plc (NASDAQ:NVET) Hit $12 Price Target? - Investor Newswire (NASDAQ:NVET)
www.investornewswire.com - August 22 at 11:08 AM
investornewswire.com logoIs $12 Price Target Attainable For Nexvet Biopharma plc (NASDAQ:NVET)? - Investor Newswire (NASDAQ:NVET)
www.investornewswire.com - July 25 at 10:59 AM
News IconNexvet Biopharma plc (NASDAQ:NVET): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily (NASDAQ:NVET)
www.engelwooddaily.com - July 22 at 9:30 AM
News IconNexvet Biopharma Plc Ord (NASDAQ:NVET) Shorted Shares Increased 32.03% After Market Selling - Consumer Eagle (NASDAQ:NVET)
www.consumereagle.com - July 22 at 9:30 AM
News IconEquity Roundup: Stock Performance Focus on Nexvet Biopharma plc (NASDAQ:NVET) - Press Telegraph (NASDAQ:NVET)
presstelegraph.com - July 20 at 9:28 AM
finance.yahoo.com logoNexvet Announces Publication of Two Peer-Reviewed Journal Articles Profiling Frunevetmab (NV-02) and Presentation at the Veterinary Pain Short Course Conference (NASDAQ:NVET)
finance.yahoo.com - July 20 at 5:30 AM
investornewswire.com logoStrong Sell Calls For Nexvet Biopharma plc (NASDAQ:NVET) At 0 - Investor Newswire (NASDAQ:NVET)
www.investornewswire.com - July 19 at 6:39 PM
News IconNexvet Biopharma plc (NASDAQ:NVET) Earnings Concentration and Analyst Target Watch - Engelwood Daily (NASDAQ:NVET)
www.engelwooddaily.com - July 15 at 11:27 AM
News IconAnalyst Target and Average Rating Watch: Nexvet Biopharma plc (NASDAQ:NVET) - Press Telegraph (NASDAQ:NVET)
presstelegraph.com - July 14 at 10:07 AM
News IconNexvet Biopharma plc (NASDAQ:NVET) Wall Street Analyst Recommendation Outlook - Telanagana Press (NASDAQ:NVET)
telanaganapress.com - July 13 at 9:30 AM
News IconNexvet Biopharma Plc Ord (NASDAQ:NVET) Short Interest Decreased By 5.62% - Press Telegraph (NASDAQ:NVET)
presstelegraph.com - July 13 at 9:30 AM
investornewswire.com logoIs $12 Within Reach For Nexvet Biopharma plc (NASDAQ:NVET)? - Investor Newswire (NASDAQ:NVET)
www.investornewswire.com - July 10 at 5:55 PM
News IconCompany Stock Focus for Nexvet Biopharma plc (NASDAQ:NVET): Which Way Will Shares Head? - Press Telegraph (NASDAQ:NVET)
presstelegraph.com - July 8 at 9:30 AM
News IconNexvet Biopharma Plc Ord (NASDAQ:NVET) Sellers Covered 5.62% of Their Shorts - Press Telegraph (NASDAQ:NVET)
presstelegraph.com - July 8 at 9:30 AM
ftsenews.co.uk logoNexvet Biopharma Plc (NVET) Updated Price Targets - FTSE News (NASDAQ:NVET)
www.ftsenews.co.uk - July 8 at 9:30 AM
fiscalstandard.com logoBroker Outlook For The Week Ahead Nexvet Biopharma Plc (NVET) - Fiscal Standard (NASDAQ:NVET)
www.fiscalstandard.com - July 5 at 6:19 PM
fiscalstandard.com logoBrokers Issue Average Price Target Of 13.00 On Nexvet Biopharma Plc (NVET) - Fiscal Standard (NASDAQ:NVET)
www.fiscalstandard.com - July 3 at 10:48 AM
News IconCovering the Bases on Nexvet Biopharma plc (NASDAQ:NVET): Where is the Stock Going? - Press Telegraph (NASDAQ:NVET)
presstelegraph.com - July 1 at 9:20 AM
News IconNexvet Biopharma plc (NASDAQ:NVET) Earnings Glance and Target Price Review - Engelwood Daily (NASDAQ:NVET)
www.engelwooddaily.com - July 1 at 9:20 AM
ftsenews.co.uk logoNew Broker Ratings For Nexvet Biopharma Plc (NVET) - FTSE News (NASDAQ:NVET)
www.ftsenews.co.uk - July 1 at 9:20 AM
News IconNexvet Biopharma Plc Ord (NASDAQ:NVET) Sellers Covered 5.62% of Their Shorts - Engelwood Daily (NASDAQ:NVET)
www.engelwooddaily.com - June 27 at 6:27 PM
investornewswire.com logoStrong Sell Calls Recommendations For Nexvet Biopharma plc (NASDAQ:NVET) At 0 - Investor Newswire (NASDAQ:NVET)
www.investornewswire.com - June 26 at 5:45 PM
stocksdaily.net logoCan Nexvet Biopharma plc (NASDAQ:NVET) Meet Analysts Expectations? - Stocks Daily (NASDAQ:NVET)
www.stocksdaily.net - June 26 at 5:45 PM
fiscalstandard.com logoRecently Issued Stock Ratings For Nexvet Biopharma Plc (NVET) - Fiscal Standard (NASDAQ:NVET)
www.fiscalstandard.com - June 25 at 6:05 PM
investornewswire.com logoStrong Buy Calls Count For Nexvet Biopharma plc (NASDAQ:NVET) At 1 - Investor Newswire (NASDAQ:NVET)
www.investornewswire.com - June 20 at 8:10 AM
fiscalstandard.com logoThis Weeks Broker Views For Nexvet Biopharma Plc (NVET) - Fiscal Standard (NASDAQ:NVET)
www.fiscalstandard.com - June 20 at 8:10 AM
investornewswire.com logoTrend Of Rating Given To Nexvet Biopharma plc (NASDAQ:NVET) - Investor Newswire (NASDAQ:NVET)
www.investornewswire.com - June 13 at 9:30 AM
capitalcube.com logoNexvet Biopharma PLC :NVET-US: Earnings Analysis: Q3, 2016 By the Numbers : June 10, 2016 (NASDAQ:NVET)
www.capitalcube.com - June 10 at 5:02 PM
finance.yahoo.com logoNexvet Biopharma (NVET) Jumps: Stock Moves 9.2% Higher (NASDAQ:NVET)
finance.yahoo.com - June 10 at 8:25 AM
News IconStock Review and Earnings Check on Nexvet Biopharma plc (NASDAQ:NVET) - HNN (NASDAQ:NVET)
hintsnewsnetwork.com - June 3 at 7:01 PM
News IconNexvet Biopharma Plc (NVET) Do Brokers Advise Buy, Sell Or Hold? - Share Trading News (NASDAQ:NVET)
www.sharetrading.news - June 2 at 9:32 AM
News IconTarget Price and Stock Performance Rundown for Nexvet Biopharma plc (NASDAQ:NVET) - HNN (NASDAQ:NVET)
hintsnewsnetwork.com - June 1 at 7:03 PM
News IconNexvet Biopharma Plc (NVET) Broker Price Targets For The Coming Week - Share Trading News (NASDAQ:NVET)
www.sharetrading.news - May 30 at 9:58 PM
News IconEarnings Review and Stock Rundown for Nexvet Biopharma plc (NASDAQ:NVET) - Wall Street Hints and News (NASDAQ:NVET)
hintsnewsnetwork.com - May 28 at 1:19 PM
publicnow.com logoNexvet Provides Update on Upcoming Investor Symposium at Irish Biomanufacturing Facility (NASDAQ:NVET)
www.publicnow.com - May 27 at 5:37 AM
News IconLatest Analyst Ratings For Nexvet Biopharma Plc (NVET) - Share Trading News (NASDAQ:NVET)
www.sharetrading.news - May 26 at 1:24 PM
baystreet.ca logoNexvet Biopharma (NVET) Flat on Study Results (NASDAQ:NVET)
www.baystreet.ca - May 26 at 1:24 PM
feeds.benzinga.com logoNexvet Biopharma Gains 15%, Company Reports Positive Results From Pilot Field Study (NASDAQ:NVET)
feeds.benzinga.com - May 26 at 10:19 AM
publicnow.com logoNexvet Announces Positive Results from NV-02 Pilot Field Study in Cats with Osteoarthritis (NASDAQ:NVET)
www.publicnow.com - May 26 at 5:57 AM
finance.yahoo.com logo5:37 am Nexvet Biopharma reports positive results from NV-02 Pilot Field Study; NV-02 Pivotal Study plans underway (NASDAQ:NVET)
finance.yahoo.com - May 26 at 5:37 AM
biz.yahoo.com logoQ3 2016 Nexvet Biopharma plc Earnings Release - Time Not Supplied (NASDAQ:NVET)
biz.yahoo.com - May 12 at 7:07 AM
publicnow.com logoNexvet Reports Financial Results for Third Quarter of Fiscal Year 2016 (NASDAQ:NVET)
www.publicnow.com - May 12 at 5:47 AM
publicnow.com logoNexvet to Host Symposium at American College of Veterinary Internal Medicine (ACVIM) Forum to Present Additional NV-01 Pivotal Data in Canine Pain and Clinical Data for NV-02 in Feline Pain (NASDAQ:NVET)
www.publicnow.com - May 11 at 6:42 AM
publicnow.com logoNexvet to Host Investor Symposium at its Irish Biomanufacturing Facility (NASDAQ:NVET)
www.publicnow.com - May 4 at 6:00 AM
publicnow.com logoNexvet and Zenoaq Announce PD-1 mAb Candidate for Canine Cancer (NASDAQ:NVET)
www.publicnow.com - May 2 at 5:40 AM
News IconNexvet Biopharma Plc (NVET) Updated Price Targets - Share Trading News (NASDAQ:NVET)
www.sharetrading.news - February 26 at 2:42 PM
noodls.com logoNexvet Biopharma plc (Nasdaq: NVET) to Ring The Nasdaq Stock Market Closing Bell (NASDAQ:NVET)
www.noodls.com - November 23 at 6:21 AM
biz.yahoo.com logoNEXVET BIOPHARMA PLC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission (NASDAQ:NVET)
biz.yahoo.com - November 20 at 4:31 PM
noodls.com logoNexvet Announces Positive Results From NV-01 Pivotal Study in Dogs With Osteoarthritis (NASDAQ:NVET)
www.noodls.com - November 16 at 6:04 AM

Social

Nexvet Biopharma PLC (NASDAQ:NVET) Chart for Tuesday, August, 30, 2016


Last Updated on 8/30/2016 by MarketBeat.com Staff